{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:21:36Z","timestamp":1759339296594,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.eimc.2022.08.001","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T07:37:37Z","timestamp":1663832257000},"page":"629-634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tratamiento y prevenci\u00f3n de la viruela del mono"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2544-3492","authenticated-orcid":false,"given":"Fernando","family":"de la Calle-Prieto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Est\u00e9banez Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germ\u00e1n","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9427-5237","authenticated-orcid":false,"given":"Marta","family":"D\u00edaz-Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4500-5222","authenticated-orcid":false,"given":"Harkaitz","family":"Azkune Galparsoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Salavert Llet\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Mata Forte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2735-5931","authenticated-orcid":false,"given":"Marta","family":"Mora-Rillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5522-3728","authenticated-orcid":false,"given":"Marta","family":"Arsuaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2749-818X","authenticated-orcid":false,"given":"Rosa","family":"de Miguel Buckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7410-9450","authenticated-orcid":false,"given":"Jose Ram\u00f3n","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Membrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2022.08.001_bib0150","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/v12111257","article-title":"Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution","volume":"12","author":"Alakunle","year":"2020","journal-title":"Viruses."},{"key":"10.1016\/j.eimc.2022.08.001_bib0155","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3201\/eid2608.191387","article-title":"Imported Monkeypox, Singapore","volume":"26","author":"Yong","year":"2020","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.eimc.2022.08.001_bib0160","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.pop.2015.08.006","article-title":"Viral Skin Diseases","volume":"42","author":"Ramdass","year":"2015","journal-title":"Prim Care."},{"key":"10.1016\/j.eimc.2022.08.001_bib0165","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.idc.2019.03.001","article-title":"Human Monkeypox: Epidemiologic and Clinical Characteristics Diagnosis, and Prevention","volume":"33","author":"Petersen","year":"2019","journal-title":"Infect Dis Clin North Am."},{"key":"10.1016\/j.eimc.2022.08.001_bib0170","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2471\/BLT.19.242347","article-title":"Modelling human-to-human transmission of monkeypox","volume":"98","author":"Grant","year":"2020","journal-title":"Bull World Health Organ."},{"key":"10.1016\/j.eimc.2022.08.001_bib0175","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1093\/cid\/ciaa143","article-title":"Clinical Course and Outcome of Human Monkeypox in Nigeria","volume":"71","author":"Ogoina","year":"2020","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2022.08.001_bib0180","doi-asserted-by":"crossref","first-page":"2200411","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200411","article-title":"Monkeypox infection presenting as genital rash, Australia, May 2022","volume":"27","author":"Hammerschlag","year":"2022","journal-title":"Euro Surveill."},{"key":"10.1016\/j.eimc.2022.08.001_bib0185","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eimc.2022.08.001_bib0190","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022","author":"Thornhill","year":"2022","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2022.08.001_bib0195","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/14787210.2020.1819791","article-title":"An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications","volume":"19","author":"Russo","year":"2021","journal-title":"Expert Rev Anti Infect Ther."},{"key":"10.1016\/j.eimc.2022.08.001_bib0200","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.vaccine.2019.10.049","article-title":"Co-administration of tecovirimat and ACAM2000TM in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge","volume":"38","author":"Russo","year":"2020","journal-title":"Vaccine."},{"key":"10.1016\/j.eimc.2022.08.001_bib0205","unstructured":"European Medicines Agency. Tecovirimat SIGA [consultado 4 Jul 2022]. Disponible en: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/tecovirimat-siga."},{"key":"10.1016\/j.eimc.2022.08.001_bib0210","unstructured":"Food and Drugs Administration. Highlights of Prescribing Information. TPOXX\u00ae [consultado 4 Jul 2022]. Disponible en: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/214518s000lbl.pdf."},{"key":"10.1016\/j.eimc.2022.08.001_bib0215","unstructured":"ClinicalTrials. Tecovirimat Intravenous Treatment for Orthopox Virus Exposure (TPOXX IV) [consultado 4 Jul 2022]. Disponible en: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05380752."},{"key":"10.1016\/j.eimc.2022.08.001_bib0220","unstructured":"Centers for Disease Control and Prevention. Guidance for Tecovirimat Use Under Expanded Access Investigational New Drug Protocol during 2022 U.S. Monkeypox Cases [consultado 16 Jul 2022]. Disponible en: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/Tecovirimat.html."},{"key":"10.1016\/j.eimc.2022.08.001_bib0230","unstructured":"European Medicines Agency. Tecovirimat SIGA, tecovirimat monohydrate. Annex I. Summary of Product Characteristics [consultado 4 Jul 2022]. Disponible en: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/tecovirimat-siga-epar-product-information_en.pdf."},{"key":"10.1016\/j.eimc.2022.08.001_bib0235","first-page":"e00927","article-title":"Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic Brincidofovir, in a Lethal Monkeypox Virus Animal Model","volume":"6","author":"Hutson","year":"2021","journal-title":"mSphere."},{"key":"10.1016\/j.eimc.2022.08.001_bib0240","unstructured":"Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Brincidofovir [consultado 4 Jul 2022]. Disponible en: https:\/\/www.aeped.es\/comite-medicamentos\/pediamecum\/brincidofovir."},{"key":"10.1016\/j.eimc.2022.08.001_bib0245","doi-asserted-by":"crossref","first-page":"105182","DOI":"10.1016\/j.antiviral.2021.105182","article-title":"Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation","volume":"195","author":"Chan-Tack","year":"2021","journal-title":"Antiviral Res."},{"key":"10.1016\/j.eimc.2022.08.001_bib0250","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/v12020138","article-title":"Smallpox in the Post-Eradication Era","volume":"12","author":"Meyer","year":"2020","journal-title":"Viruses."},{"key":"10.1016\/j.eimc.2022.08.001_bib0255","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Ficha t\u00e9cnica cidofovir trillomed 75 mg\/ml concentrado para soluci\u00f3n para perfusi\u00f3n EFG [consultado 4 Jul 2022]. Disponible en: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/81303\/FT_81303.html"},{"key":"10.1016\/j.eimc.2022.08.001_bib0260","doi-asserted-by":"crossref","first-page":"509","DOI":"10.15585\/mmwr.mm7114a1","article-title":"Monkeypox in a Traveler Returning from Nigeria - Dallas, Texas, July 2021","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.eimc.2022.08.001_bib0265","unstructured":"Ministerio de Sanidad. Alerta de viruela del mono en Espa\u00f1a y a nivel mundial [consultado 22 Jul 2022]. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/alertaMonkeypox\/home.htm."},{"key":"10.1016\/j.eimc.2022.08.001_bib0270","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3201\/eid2704.203569","article-title":"Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017-2020","volume":"27","author":"Nguyen","year":"2021","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.eimc.2022.08.001_bib0275","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","article-title":"Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.eimc.2022.08.001_bib0280","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med."},{"key":"10.1016\/j.eimc.2022.08.001_bib0285","unstructured":"U.S. Food and Drug Administration. JYNNEOS [consultado 4 Jul 2022]. Disponible en: https:\/\/www.fda.gov\/vaccines-blood-biologics\/jynneos."},{"key":"10.1016\/j.eimc.2022.08.001_bib0290","unstructured":"ClinicalTrials.gov. Cohort Study of Healthcare Workers Receiving Imvanex\u00ae [consultado 16 Jul 2022]. Disponible en: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03745131."}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X22001677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X22001677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:09:40Z","timestamp":1759324180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X22001677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0213005X22001677"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2022.08.001","relation":{},"ISSN":["0213-005X"],"issn-type":[{"type":"print","value":"0213-005X"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tratamiento y prevenci\u00f3n de la viruela del mono","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2022.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}